Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhabdomyosarcoma, Abdominal”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)WithdrawnNCT03111069
What this trial is testing

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Who this might be right for
Malignant Neoplasms of Mesothelial and Soft TissueRhabdomyosarcoma, PelvicRhabdomyosarcoma, Abdominal
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00436657
What this trial is testing

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

Who this might be right for
Peritoneal NeoplasmsRetroperitoneal NeoplasmsGastrointestinal Neoplasms+8 more
M.D. Anderson Cancer Center 10
Very early researchEnded earlyNCT04213794
What this trial is testing

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients

Who this might be right for
Malignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more
Mayo Clinic 2